Cargando…
Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target
Direct-acting antivirals are effective tools to control viral infections. SARS-CoV-2 is a coronavirus associated with the epidemiological outbreak in late 2019. Previous reports showed that HIV-1 protease inhibitors could block SARS-CoV main protease. Based on that and using an in silico approach, w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081067/ https://www.ncbi.nlm.nih.gov/pubmed/32210741 http://dx.doi.org/10.17179/excli2020-1189 |
_version_ | 1783508108821135360 |
---|---|
author | Ortega, Joseph Thomas Serrano, Maria Luisa Pujol, Flor Helene Rangel, Hector Rafael |
author_facet | Ortega, Joseph Thomas Serrano, Maria Luisa Pujol, Flor Helene Rangel, Hector Rafael |
author_sort | Ortega, Joseph Thomas |
collection | PubMed |
description | Direct-acting antivirals are effective tools to control viral infections. SARS-CoV-2 is a coronavirus associated with the epidemiological outbreak in late 2019. Previous reports showed that HIV-1 protease inhibitors could block SARS-CoV main protease. Based on that and using an in silico approach, we evaluated SARS-CoV-2 main protease as a target for HIV-1 protease inhibitors to reveal the structural features related to their antiviral effect. Our results showed that several HIV inhibitors such as lopinavir, ritonavir, and saquinavir produce strong interaction with the active site of SARS-CoV-2 main protease. Furthermore, broad library protease inhibitors obtained from PubChem and ZINC (www.zinc.docking.org) were evaluated. Our analysis revealed 20 compounds that could be clustered into three groups based on their chemical features. Then, these structures could serve as leading compounds to develop a series of derivatives optimizing their activity against SARS-CoV-2 and other coronaviruses. Altogether, the results presented in this work contribute to gain a deep understanding of the molecular pharmacology of SARS-CoV-2 treatment and validate the use of protease inhibitors against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7081067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Leibniz Research Centre for Working Environment and Human Factors |
record_format | MEDLINE/PubMed |
spelling | pubmed-70810672020-03-24 Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target Ortega, Joseph Thomas Serrano, Maria Luisa Pujol, Flor Helene Rangel, Hector Rafael EXCLI J Original Article Direct-acting antivirals are effective tools to control viral infections. SARS-CoV-2 is a coronavirus associated with the epidemiological outbreak in late 2019. Previous reports showed that HIV-1 protease inhibitors could block SARS-CoV main protease. Based on that and using an in silico approach, we evaluated SARS-CoV-2 main protease as a target for HIV-1 protease inhibitors to reveal the structural features related to their antiviral effect. Our results showed that several HIV inhibitors such as lopinavir, ritonavir, and saquinavir produce strong interaction with the active site of SARS-CoV-2 main protease. Furthermore, broad library protease inhibitors obtained from PubChem and ZINC (www.zinc.docking.org) were evaluated. Our analysis revealed 20 compounds that could be clustered into three groups based on their chemical features. Then, these structures could serve as leading compounds to develop a series of derivatives optimizing their activity against SARS-CoV-2 and other coronaviruses. Altogether, the results presented in this work contribute to gain a deep understanding of the molecular pharmacology of SARS-CoV-2 treatment and validate the use of protease inhibitors against SARS-CoV-2. Leibniz Research Centre for Working Environment and Human Factors 2020-03-17 /pmc/articles/PMC7081067/ /pubmed/32210741 http://dx.doi.org/10.17179/excli2020-1189 Text en Copyright © 2020 Ortega et al. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited. |
spellingShingle | Original Article Ortega, Joseph Thomas Serrano, Maria Luisa Pujol, Flor Helene Rangel, Hector Rafael Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title_full | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title_fullStr | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title_full_unstemmed | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title_short | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
title_sort | unrevealing sequence and structural features of novel coronavirus using in silico approaches: the main protease as molecular target |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081067/ https://www.ncbi.nlm.nih.gov/pubmed/32210741 http://dx.doi.org/10.17179/excli2020-1189 |
work_keys_str_mv | AT ortegajosephthomas unrevealingsequenceandstructuralfeaturesofnovelcoronavirususinginsilicoapproachesthemainproteaseasmoleculartarget AT serranomarialuisa unrevealingsequenceandstructuralfeaturesofnovelcoronavirususinginsilicoapproachesthemainproteaseasmoleculartarget AT pujolflorhelene unrevealingsequenceandstructuralfeaturesofnovelcoronavirususinginsilicoapproachesthemainproteaseasmoleculartarget AT rangelhectorrafael unrevealingsequenceandstructuralfeaturesofnovelcoronavirususinginsilicoapproachesthemainproteaseasmoleculartarget |